Evaluation of candidate vaccine approaches for MERS-CoV

Abstract

The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) as a cause of severe respiratory disease highlights the need for effective approaches to CoV vaccine development. Efforts focused solely on the receptor-binding domain (RBD) of the viral Spike (S) glycoprotein may not optimize neutralizing antibody (NAb) responses. Here we show that immunogens based on full-length S DNA and S1 subunit protein elicit robust serum-neutralizing activity against several MERS-CoV strains in mice and non-human primates. Serological analysis and isolation of murine monoclonal antibodies revealed that immunization elicits NAbs to RBD and, non-RBD portions of S1 and S2 subunit. Multiple neutralization mechanisms were demonstrated by solving the atomic structure of a NAb-RBD complex, through sequencing of neutralization escape viruses and by constructing MERS-CoV S variants for serological assays. Immunization of rhesus macaques confers protection against MERS-CoV-induced radiographic pneumonia, as assessed using computerized tomography, supporting this strategy as a promising approach for MERS-CoV vaccine development.

Cited by papers we hold 17

• Current advances in the development of SARS-CoV-2 vaccines · 2021
  No notice
• Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2 · 2021
  No notice
• The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies · 2020
  No notice
• Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses · 2020
  No notice
• The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens · 2020
  No notice
• Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition · 2020
  No notice
• COVID-19: Coronavirus Vaccine Development Updates · 2020
  No notice
• An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies · 2020
  Corrected
• Adjuvants for Coronavirus Vaccines · 2020
  No notice
• From SARS to MERS, Thrusting Coronaviruses into the Spotlight · 2019
  No notice
• Epitope‐based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study · 2019
  No notice
• Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus · 2019
  No notice
• MERS-CoV: Understanding the Latest Human Coronavirus Threat · 2018
  No notice
• Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development · 2017
  No notice
• ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice · 2017
  No notice
• Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains · 2017
  No notice
• MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.